AMRX
NASDAQ · Pharmaceuticals
Amneal Pharmaceuticals Inc
$12.07
+0.15 (+1.26%)
Performance
1D
—
1W
—
1M
—
3M
-6.80%
6M
+23.79%
1Y
+41.50%
YTD
-4.66%
Open$11.77
Previous Close$11.92
Day High$12.13
Day Low$11.71
52W High$15.42
52W Low$6.69
Volume—
Avg Volume2.12M
Market Cap4.12B
P/E Ratio57.11
EPS$0.22
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$13.39
Below
SMA 200
$10.30
Above
RSI (14)
57.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
11 analysts
Price Target
+857.2% upside
Current
$12.07
$12.07
Target
$115.54
$115.54
$65.43
$115.54 avg
$156.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.89B | 2.60B | 607.96M |
| Net Income | 68.94M | 55.94M | 209.30M |
| Profit Margin | 2.4% | 2.3% | 34.4% |
| EBITDA | 570.59M | 488.69M | 317.16M |
| Free Cash Flow | — | — | 187.04M |
| Rev Growth | +10.9% | +10.9% | -4.4% |
| Debt/Equity | 136.58 | 136.58 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $903.02 | -0.83% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $235.27 | -0.06% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $116.37 | +0.60% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $26.96 | +0.71% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $57.39 | +0.68% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $115.93 | +0.61% | 21.5 | 57.37B |